TGAN vs. CAN, AIP, QUIK, KOPN, AXTI, VLN, MX, NVEC, PXLW, and ATOM
Should you be buying Transphorm stock or one of its competitors? The main competitors of Transphorm include Canaan (CAN), Arteris (AIP), QuickLogic (QUIK), Kopin (KOPN), AXT (AXTI), Valens Semiconductor (VLN), Magnachip Semiconductor (MX), NVE (NVEC), Pixelworks (PXLW), and Atomera (ATOM). These companies are all part of the "semiconductors & related devices" industry.
Transphorm (NASDAQ:TGAN) and Canaan (NASDAQ:CAN) are both small-cap computer and technology companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, risk, media sentiment, earnings, community ranking, dividends, analyst recommendations, institutional ownership and valuation.
Canaan received 8 more outperform votes than Transphorm when rated by MarketBeat users. Likewise, 58.82% of users gave Canaan an outperform vote while only 50.00% of users gave Transphorm an outperform vote.
In the previous week, Canaan had 4 more articles in the media than Transphorm. MarketBeat recorded 6 mentions for Canaan and 2 mentions for Transphorm. Transphorm's average media sentiment score of 0.63 beat Canaan's score of 0.35 indicating that Transphorm is being referred to more favorably in the media.
Transphorm has higher earnings, but lower revenue than Canaan. Transphorm is trading at a lower price-to-earnings ratio than Canaan, indicating that it is currently the more affordable of the two stocks.
Transphorm presently has a consensus price target of $5.75, suggesting a potential upside of 17.11%. Canaan has a consensus price target of $4.25, suggesting a potential upside of 179.61%. Given Canaan's stronger consensus rating and higher possible upside, analysts plainly believe Canaan is more favorable than Transphorm.
Transphorm has a beta of 0.58, meaning that its share price is 42% less volatile than the S&P 500. Comparatively, Canaan has a beta of 3.02, meaning that its share price is 202% more volatile than the S&P 500.
Transphorm has a net margin of -177.91% compared to Canaan's net margin of -195.84%. Canaan's return on equity of -80.13% beat Transphorm's return on equity.
66.5% of Transphorm shares are owned by institutional investors. Comparatively, 70.1% of Canaan shares are owned by institutional investors. 2.5% of Transphorm shares are owned by company insiders. Comparatively, 0.3% of Canaan shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Summary
Canaan beats Transphorm on 12 of the 18 factors compared between the two stocks.
Get Transphorm News Delivered to You Automatically
Sign up to receive the latest news and ratings for TGAN and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding TGAN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartThis chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Transphorm Competitors List
Related Companies and Tools